These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6594240)

  • 1. Bactericidal activity of imipenem in serum.
    Machka K
    Eur J Clin Microbiol; 1984 Oct; 3(5):495-7. PubMed ID: 6594240
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-resistance and imipenem.
    Calandra G; Ricci F; Wang C; Brown K
    Lancet; 1986 Aug; 2(8502):340-1. PubMed ID: 2874348
    [No Abstract]   [Full Text] [Related]  

  • 3. BO-2727, meropenem and imipenem disc diffusion susceptibility testing criteria.
    Barry AL; Fuchs PC
    J Antimicrob Chemother; 1995 Aug; 36(2):444-6. PubMed ID: 8522478
    [No Abstract]   [Full Text] [Related]  

  • 4. Bactericidal activity of imipenem in broth, serum and in the presence of human polymorphonuclear leukocytes against staphylococcus aureus and Klebsiella pneumoniae.
    Bassler M; Just HM; Gelbke H; Daschner F
    Eur J Clin Microbiol; 1984 Oct; 3(5):493-5. PubMed ID: 6389128
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity of imipenem against anaerobic bacteria.
    Megran D; Carlson C; Chow A
    Eur J Clin Microbiol; 1984 Oct; 3(5):488-9. PubMed ID: 6594238
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of HR 810, a new cephalosporin.
    Bertram MA; Bruckner DA; Young LS
    Antimicrob Agents Chemother; 1984 Aug; 26(2):277-9. PubMed ID: 6593000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipenem: morphological changes and lethal effects on Pseudomonas aeruginosa.
    Carlone NA; Ferrero M; Cuffini AM; Cavallo R
    Drugs Exp Clin Res; 1987; 13(10):623-9. PubMed ID: 3123190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria.
    Piddock LJ; Johnson MM; Webber MA
    J Antimicrob Chemother; 2003 Sep; 52(3):500-2. PubMed ID: 12917244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
    Bauernfeind A
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():155-64. PubMed ID: 3897170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ciprofloxacin in combination with other antimicrobial substances].
    Shah PM; Mellinghoff D; Stille W
    Arzneimittelforschung; 1988 Mar; 38(3):411-5. PubMed ID: 3164186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
    Calandra GB; Hesney M; Grad C
    Eur J Clin Microbiol; 1984 Oct; 3(5):478-87. PubMed ID: 6389126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem: a new carbapenem. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.
    CMAJ; 1988 Sep; 139(6):505-6. PubMed ID: 3044554
    [No Abstract]   [Full Text] [Related]  

  • 13. RO23-6240, a new orally absorbed quinolone: in vitro comparison with other broad-spectrum oral antimicrobial agents and imipenem.
    Aldridge KE; Schiro DD; Sanders CV
    Diagn Microbiol Infect Dis; 1987 May; 7(1):9-19. PubMed ID: 3121244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of imipenem towards gram-negative bacilli.
    Speciale A; Caccamo F; Pellegrino MB; Blandino G; Nicoletti G
    Chemioterapia; 1986 Oct; 5(5):291-6. PubMed ID: 3466723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
    Owens WE; Finegold SM
    Antimicrob Agents Chemother; 1983 Apr; 23(4):626-9. PubMed ID: 6305265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of imipenem in an in-vitro model simulating pharmacokinetic parameters in human blood.
    Shah PM
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():153-7. PubMed ID: 3856562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
    Bartmann K; Tarbuc R
    Infection; 1982; 10(6):361-70. PubMed ID: 6818153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of imipenem--a review.
    Braveny I
    Eur J Clin Microbiol; 1984 Oct; 3(5):456-62. PubMed ID: 6389125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bactericidal activity of biapenem against various efflux system mutants of Pseudomonas aeruginosa].
    Hiraishi T; Miyata A; Takata T; Araake M; Ogawa H; Gotoh N; Nishino T
    Jpn J Antibiot; 2002 Feb; 55(1):67-76. PubMed ID: 11977922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of stably derepressed beta-lactamase producing strains to imipenem and four quinolones.
    Jones RN; Barry AL
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):82-3. PubMed ID: 3132387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.